Frontlight ResearchEarly access
Trial site
Taipei
- 12running trials
- 2closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Haemophilia3 trials
- CIDP (chronic inflammatory demyelinating polyneuropathy)2 trials
- COPD2 trials
- Multiple sclerosis2 trials
- Asthma1 trial
- Crohn's disease1 trial
- Fabry disease1 trial
- Multiple myeloma1 trial
- Nephrotic syndrome1 trial
- Phase
- Phase 38 trials
- Phase 43 trials
- Phase 21 trial
- Status
- Active, not recruiting6 trials
- Recruiting6 trials
- Completed2 trials
- Lead sponsor
- Sanofi13 trials
- Bioverativ, a Sanofi company1 trial
Running trials
Recruiting
Recruiting
Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- COPD2 recruiting
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
- Crohn's disease1 recruiting
- Haemophilia1 recruiting
- Nephrotic syndrome1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 15 Nov 2026